0.0919
7.61%
0.0065
Handel nachbörslich:
.09
-0.0019
-2.07%
Schlusskurs vom Vortag:
$0.0854
Offen:
$0.0862
24-Stunden-Volumen:
5.45M
Relative Volume:
0.45
Marktkapitalisierung:
$8.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.21M
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-8.10%
1M Leistung:
-18.24%
6M Leistung:
-96.91%
1J Leistung:
-92.65%
Conduit Pharmaceuticals Inc Stock (CDT) Company Profile
Firmenname
Conduit Pharmaceuticals Inc
Sektor
Branche
Telefon
(646) 491 9132
Adresse
4851 TAMIAMI TRAIL NORTH, NAPLES
Vergleichen Sie CDT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
CDT | 0.0919 | 8.76M | 0 | -4.21M | 0 | 0.00 |
VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Conduit Pharmaceuticals Inc Aktie (CDT) Neueste Nachrichten
Conduit Pharmaceuticals announces restatement of financials - Investing.com
Remitly Global Inc (NASDAQ: RELY) Is The Number One Stock Currently Moving. - Stocks Register
Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews
Conduit Pharmaceuticals announces new addition to autoimmune pipeline - Yahoo Finance
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline - StockTitan
Conduit Pharmaceuticals Opens New Lab Space In Cambridge, UK - Contract Pharma
Conduit Pharmaceuticals secures $1.2 million in funding - Investing.com India
Conduit Pharmaceuticals secures $1.2 million in funding By Investing.com - Investing.com South Africa
Conduit Pharmaceuticals announces debt restructuring and additional notes - MSN
Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes - The Manila Times
LeMaitre to Participate at Upcoming Investor Conferences in November - The Manila Times
Conduit Pharmaceuticals Secures Funding and Modifies Debt Agreements - TipRanks
Prologis Inc (NYSE: PLD): Forecast Strong In 2024, Up 18.49% - Stocks Register
Where Do Analysts Think The Conduit Pharmaceuticals Inc (NASDAQ: CDT) Is Going - Stocks Register
Presidio Property Trust Provides Update on Model Home Activity in Q3 2024 - The Manila Times
Conduit Pharmaceuticals announces debt restructuring By Investing.com - Investing.com Australia
Conduit Pharmaceuticals announces debt restructuring - Investing.com India
CDT Stock on the Rise: A Promising Investment - The InvestChronicle
Conduit Pharmaceuticals Inc [CDT] Insider Nirland Ltd sells 1,500,000 Shares – Insider Selling Alert - Knox Daily
Investing in Capricor Therapeutics Inc (CAPR): What You Must Know - Knox Daily
A stock that deserves closer examination: Conduit Pharmaceuticals Inc (CDT) - US Post News
CDT’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Selling Buzz: Conduit Pharmaceuticals Inc [CDT] 10% Owner Nirland Ltd sells 1,500,000 shares of the company - Knox Daily
Astrazeneca PLC Reports 9.9% Passive Stake In Conduit Pharmaceuticals Inc As Of August 7SEC Filing - XM
There is no way Conduit Pharmaceuticals Inc (CDT) can keep these numbers up - SETE News
Conduit Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
Ltd Nirland Sells 939,009 Shares of Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Stock - Defense World
Conduit Pharmaceuticals insiders sell shares worth over $393k By Investing.com - Investing.com South Africa
Conduit Pharmaceuticals insiders sell shares worth over $393k - Investing.com
Market cap of Conduit Pharmaceuticals Inc [CDT] reaches 9.50M – now what? - The DBT News
Examining Conduit Pharmaceuticals Inc (CDT) more closely is necessary - US Post News
Balance Sheet Dive: Conduit Pharmaceuticals Inc (CDT)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Conduit Pharmaceuticals Inc [CDT] Records 50-Day SMA of $0.1531 - Knox Daily
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Conduit Pharmaceuticals executives sell shares worth over $297k By Investing.com - Investing.com Canada
Conduit Pharmaceuticals executives sell shares worth over $297k - Investing.com
Insider Selling: Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Major Shareholder Sells 1,016,823 Shares of Stock - Defense World
Conduit Pharmaceuticals Inc (CDT) expanding its growth trajectory ahead - SETE News
Market cap of Conduit Pharmaceuticals Inc [CDT] reaches 10.18M – now what? - The DBT News
Conduit Pharmaceuticals Inc [CDT] Insider Regan Andrew sells 10,244,392 Shares – Insider Selling Alert - Knox Daily
CDT stock plunges to 52-week low, touches $0.11 amid market challenges - Investing.com Canada
Presidio Property Trust Announces Series D Preferred Stock Cash Dividend - The Manila Times
In the Green: Conduit Pharmaceuticals Inc (CDT) Closes at 0.13, Up/Down -2.64 from Previous Day - The Dwinnex
CDT Stock Sees Decline of Approximately -3.66% in Last Five Days - Knox Daily
Conduit Pharmaceuticals Inc [CDT] Insider Activity: An Update for Investors - Knox Daily
Metric Analysis: Conduit Pharmaceuticals Inc (CDT)’s Key Ratios in the Limelight - The Dwinnex
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Director Andrew Regan Sells 1,514,100 Shares - Defense World
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Director Andrew Regan Sells 150,000 Shares of Stock - Defense World
CDT Shares Experience Decline in Value - Knox Daily
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Director Andrew Regan Sells 35,923 Shares - Defense World
Mercer Global Advisors Inc. ADV Reduces Stock Position in Dimensional Emerging Markets Core Equity 2 ETF (NYSEARCA:DFEM) - Defense World
Finanzdaten der Conduit Pharmaceuticals Inc-Aktie (CDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):